Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
OncoSec Announces Appointment of George Chi as Chief Financial Officer
OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on developing […]
BIORCHESTRA Announces 45 Million USD Series C Fundraising
BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using […]
Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer
Mnemo Therapeutics, a biotechnology company developing next-generation T cell therapies, today announced the appointment of Robert […]
BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing […]
TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients
TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, […]
PrecisionLife Announces Appointment of Colin Stubberfield as SVP Drug Discovery to Lead Development of its Precision Medicine Programs
PrecisionLife Limited, a global techbio company driving precision medicine in chronic diseases with drug discovery, […]
Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer
Biosion, Inc. (“Biosion”), a global clinical stage biotechnology company, today announced the appointment of Joel Edwards as […]
GuideWell and Olive Debut First-Of-Its-Kind AI Solution to Accelerate Access to Health Care
GuideWell, a health solutions company and parent to the leading health insurer in Florida, and […]
Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, […]
SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline
SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more